Telomeres and immunological diseases of aging
- PMID: 20016137
- PMCID: PMC2917738
- DOI: 10.1159/000268620
Telomeres and immunological diseases of aging
Abstract
A defining feature of the eukaryotic genome is the presence of linear chromosomes. This arrangement, however, poses several challenges with regard to chromosomal replication and maintenance. To prevent the loss of coding sequences and to suppress gross chromosomal rearrangements, linear chromosomes are capped by repetitive nucleoprotein structures, called telomeres. Each cell division results in a progressive shortening of telomeres that, below a certain threshold, promotes genome instability, senescence, and apoptosis. Telomeric erosion, maintenance, and repair take center stage in determining cell fate. Cells of the immune system are under enormous proliferative demand, stressing telomeric intactness. Lymphocytes are capable of upregulating telomerase, an enzyme that can elongate telomeric sequences and, thus, prolong cellular lifespan. Therefore, telomere dynamics are critical in preserving immune function and have become a focus for studies of immunosenescence and autoimmunity. In this review, we describe the role of telomeric nucleoproteins in shaping telomere architecture and in suppressing DNA damage responses. We summarize new insights into the regulation of telomerase activity, hereditary disorders associated with telomere dysfunction, the role of telomere loss in immune aging, and the impact of telomere dysfunction in chronic inflammatory disease.
Copyright 2009 S. Karger AG, Basel.
Figures
Similar articles
-
The telomere/telomerase system in autoimmune and systemic immune-mediated diseases.Autoimmun Rev. 2010 Aug;9(10):646-51. doi: 10.1016/j.autrev.2010.04.004. Epub 2010 May 6. Autoimmun Rev. 2010. PMID: 20435169 Review.
-
Telomeres, immune aging and autoimmunity.Exp Gerontol. 2006 Mar;41(3):246-51. doi: 10.1016/j.exger.2005.12.002. Epub 2006 Jan 19. Exp Gerontol. 2006. PMID: 16427234 Review.
-
Tieing together loose ends: telomere instability in cancer and aging.Mol Oncol. 2022 Sep;16(18):3380-3396. doi: 10.1002/1878-0261.13299. Epub 2022 Aug 16. Mol Oncol. 2022. PMID: 35920280 Free PMC article. Review.
-
Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.Curr Stem Cell Res Ther. 2021;16(7):809-823. doi: 10.2174/1574888X15666200422104423. Curr Stem Cell Res Ther. 2021. PMID: 32321410 Review.
-
Immunosenescence phenotypes in the telomerase knockout mouse.Springer Semin Immunopathol. 2002;24(1):75-85. doi: 10.1007/s00281-001-0096-1. Springer Semin Immunopathol. 2002. PMID: 11974584 Review.
Cited by
-
Platelet-Rich Plasma Proteome of Mares Susceptible to Persistent-Breeding-Induced Endometritis Differs from Resistant Mares.Animals (Basel). 2024 Jul 18;14(14):2100. doi: 10.3390/ani14142100. Animals (Basel). 2024. PMID: 39061562 Free PMC article.
-
Telomeres and early-life stress: an overview.Biol Psychiatry. 2013 Jan 1;73(1):15-23. doi: 10.1016/j.biopsych.2012.06.025. Epub 2012 Jul 24. Biol Psychiatry. 2013. PMID: 22831981 Free PMC article. Review.
-
Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):399-406. doi: 10.1097/QAI.0000000000001824. J Acquir Immune Defic Syndr. 2018. PMID: 30312276 Free PMC article.
-
Physical activity and telomere length in early stage breast cancer survivors.Breast Cancer Res. 2014 Jul 31;16(4):413. doi: 10.1186/s13058-014-0413-y. Breast Cancer Res. 2014. PMID: 25074648 Free PMC article.
-
Potent telomerase activators from a novel sapogenin via biotransformation utilizing Camarosporium laburnicola, an endophytic fungus.Microb Cell Fact. 2023 Apr 6;22(1):66. doi: 10.1186/s12934-023-02069-3. Microb Cell Fact. 2023. PMID: 37024895 Free PMC article.
References
-
- Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006;236:13–23. - PubMed
-
- Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2005;26:867–874. - PubMed
-
- Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet. 2008;42:301–334. - PubMed
-
- Bollmann FM. The many faces of telomerase: emerging extratelomeric effects. Bioessays. 2008;30:728–732. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR41974/AR/NIAMS NIH HHS/United States
- R01 AI044142/AI/NIAID NIH HHS/United States
- R01 AR041974/AR/NIAMS NIH HHS/United States
- R01 EY11916/EY/NEI NIH HHS/United States
- R01 HL117913/HL/NHLBI NIH HHS/United States
- R01 AR42527/AR/NIAMS NIH HHS/United States
- R01 AI108906/AI/NIAID NIH HHS/United States
- R01 AI44142/AI/NIAID NIH HHS/United States
- R01 EY011916/EY/NEI NIH HHS/United States
- R01 AG015043/AG/NIA NIH HHS/United States
- U19 AI057266/AI/NIAID NIH HHS/United States
- R01 AR042527/AR/NIAMS NIH HHS/United States
- R56 AI044142/AI/NIAID NIH HHS/United States
- R01 AG15043/AG/NIA NIH HHS/United States
- U19 AI57266/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical